课题基金 / 基金详情

Targeting PRMT1 in Clear Cell Renal Cell Carcinoma

Targeting PRMT1 in Clear Cell Renal Cell Carcinoma
透明细胞肾细胞癌中的靶向 PRMT1
批准号：
477253
负责人：
Ailles Laurie E
金额：
$7.29万
依托单位：
Princess Margaret Cancer Centre (Toronto)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2022
资助国家：
加拿大
项目状态：
已结题
起止时间：
2022-10-01 至 2023-10-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=477253&lang=en
关键词：
Clear Cell Renal Cell Carcinoma Dna Damage Response Patient-Derived Models Prmt1

项目摘要

项目成果

Ailles Laurie E的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Clear cell renal cell carcinoma (ccRCC) is the most common type of kidney cancer. If discovered early, patients can be cured upon surgical resection of the tumor. However, in more advanced disease, treatment options are limited because ccRCC does not resp
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting PRMT1 in Clear Cell Renal Cell Carcinoma
Prognostic Biomarkers and Novel Therapies for Oral Squamous Cell Carcinoma Patients
Functional and Genetic Heterogeneity in Oral Squamous Cell Carcinoma
Functional and Molecular Characterization of Cancer-Associated Fibroblasts in High Grade Serous Ovarian Cancer
海外基金